FP7Индивидуална стипендия2008–2010

SRF COFACTORS · Cell Biology of SRF cofactors

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2008-06-01 → 2010-05-31
Финансиране от ЕС
177 740 €
Участници
1
Схема
MC-IEF

Линиите свързват координатора с партньорите.

Накратко на български

Механизмът, чрез който протеинът MAL реагира на нивата на актин, се анализира чрез рентгенова кристалография. Разбирането на тези процеси помага да се разбере как се контролират деленето, движението и развитието на клетките в многоклетъчните организми.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Cell biology of SRF cofactors

Development and function of a multicellular organism requires a complex interplay between cells and a tight control of proliferation and differentiation. Cells respond to extracellular signals with changes in their gene expression pattern, a process which is regulated by transcription factors. SRF (serum response factor) is a transcription factor which regulates many immediate early genes as well as many genes controlling cell adhesion and migration. The third major group of SRF targets are muscle-specific genes. Differential regulation of SRF-activity is achieved by mutually exclusive binding of specific coactivators. MAL (MRTF-A/MKL1), a coactivator of the myocardin family, links SRF activity to actin. MAL localisation and transcriptional activity is controlled through regulated interaction with monomeric G-actin. Stimulation with serum leads to actin-polymerisation and G-actin depletion. Upon G-actin depletion MAL accumulates in the nucleus, where it activates transcription (Miralles et al. (2003) Cell 113(3): 329-42, reviewed in Posern and Treisman (2006) Trends Cell Biol 16(11): 588-96). Aim of this project was to understand the mechanism by which G-actin binding controls these events. MAL senses the G-actin levels in the cell with a so-called RPEL domain. It consists of three RPEL motifs, which are connected by linker-sequences (Miralles et al. (2003) Cell 113(3): 329-42). To investigate the nature of the actin-binding to the RPEL domain and the stoichiometry of the complex, we applied x-ray crystallography in collaboration with Sebastian Guettler, Stephane Mouilleron and Neil McDonald. We obtained crystal-structures for the isolated RPEL1 and RPEL2-motif bound to latB-actin. Both RPEL peptides bound to actin mainly through hydrophobic interactions via two alpha-helices and a C-terminal capping region (Mouilleron et al. (2008) EMBO J 27: 3198-3208). To get more insight into the stoichiometry of the actin-MAL complex, we crystallised full RPEL domain bound to latB-actin. We obtained two distinct structures, one with three actins bound to the RPEL domain, one with five actins. To validate these results in a biological context, we disrupted MAL-actin binding by site-directed mutagenesis of crucial actin binding residues in full-length MAL and assessed their behaviour in a cell based localisation and activation assay. All disrupting mutations caused partial MAL-deregulation, which supports the structural model. To study changes in the MAL-actin interaction during signalling we planned to use FRET analysis in live cells. FRET (Forster resonance energy transfer) is a photophysical effect, which can be used to monitor transient protein-protein interactions. Fluorescent proteins can be genetically fused to the proteins of interest and be used for analysis of protein-protein interactions in a live cell environment. We were trying to monitor the MAL-actin interactions using MAL-GFP and mcherry-actin as a FRET-pair. In fixed cells we could observe FRET between MAL-GFP and mcherry-actin in serum-starved cells, indicating an interaction between these two proteins. FRET was abolished when the cells were treated with a drug that disrupts MAL-actin binding. However, the effect was very small, which makes this system not applicable for in vivo work. Current work aims to improve the FRET-efficiency. This project is carried out in collaboration with Banafshe Larijani. MAL is implicated in cell motility and metastasis (Medjikane et al. (2009) Nat Cell Biol 11(3): 257-268), which makes this pathway interesting as a potential target for new cancer therapies. Deeper understanding of the MAL-actin interaction might prove useful in the fight against cancer. From the crystal-structures combined with the site-directed mutagenesis we were able to define crucial actin binding residues in MAL. This might be a first step into new therapeutic avenues. richard.treisman@cancer.org.uk carola.langer@cancer.org.uk

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Serum response factor (SRF) regulates the expression of immediate-early genes as well as the expression of many muscle-specific genes. Differential regulation of the expression is achieved by exclusive binding of specific coactivators. MAL and MKL2, two coactivators of the myocardin family link SRF activity to a Rho-actin signalling pathway. Their activity is controlled through regulated interaction with G-actin, which is mediated by an RPEL domain. Rho-activation and G-actin depletion leads to accumulation of MAL in the nucleus where it activates transcription. Recent results show, that actin binding controls MAL activity at multiple levels. Actin binding inhibits MAL nuclear import, promotes MAL nuclear export and inhibits transcriptional activation by MAL. A major unresolved question is the mechanism by which actin binding regulates these events. In the proposed project, I will address this question by developing a system to track MAL in real time and study the interactions between MAL and actin and between MAL and SRF in live cells. I plan to use FRET/FLIM to assess the real time dynamics and changes in the localisation of MAL-actin interactions and the interaction of isolated RPEL domain with actin. I will investigate the stoichiometry of MAL-actin interaction, in vivo as well as in vitro. I will use FRAP analysis to assess changes in the mobility of MAL following stimulation, and compare the kinetics with that previous obtained for the MAL-actin interaction by FRET, and perform detailed in vitro actin binding studies. Additionally, I plan to elucidate actin’s interaction with members of the other family of RPEL motif-containing proteins, the Phactr/Scapinin family. By applying this wide variety of biophysical techniques I hope to understand the mechanism of the actin-dependent regulation of MAL activity in more detail.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз